cbdMD, Inc. (YCBD-PA)

USD 0.68

(1.49%)

Operating Expenses Summary of cbdMD, Inc.

cbdMD, Inc.'s latest annual operating expenses in 2023 was 24.24 Million USD , down -38.71% from previous year.
cbdMD, Inc.'s latest quarterly operating expenses in 2024 Q3 was 3.49 Million USD , down -8.38% from previous quarter.
cbdMD, Inc. reported a annual operating expenses of 39.55 Million USD in annual operating expenses 2022, down -20.25% from previous year.
cbdMD, Inc. reported a annual operating expenses of 49.6 Million USD in annual operating expenses 2021, up 12.86% from previous year.
cbdMD, Inc. reported a quarterly operating expenses of 4.13 Million USD for 2024 Q2, down -3.28% from previous quarter.
cbdMD, Inc. reported a quarterly operating expenses of 3.49 Million USD for 2024 Q3, down -8.38% from previous quarter.

Annual Operating Expenses Chart of cbdMD, Inc. (2023 - 2016)

Historical Annual Operating Expenses of cbdMD, Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	24.24 Million USD	-38.71%
2022	39.55 Million USD	-20.25%
2021	49.6 Million USD	12.86%
2020	43.95 Million USD	52.21%
2019	28.87 Million USD	412.9%
2018	5.62 Million USD	67.61%
2017	3.35 Million USD	-18.99%
2016	4.14 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	4.27 Million USD	-22.98%
2024 Q2	4.13 Million USD	-3.28%
2024 Q3	3.49 Million USD	-8.38%
2023 Q4	5.54 Million USD	-2.16%
2023 Q3	5.66 Million USD	4.67%
2023 FY	24.24 Million USD	-38.71%
2023 Q1	7.61 Million USD	-3.22%
2023 Q2	5.41 Million USD	-28.87%
2022 Q2	11.45 Million USD	-4.2%
2022 Q4	7.86 Million USD	-5.02%
2022 FY	39.55 Million USD	-20.25%
2022 Q1	11.95 Million USD	-6.27%
2022 Q3	8.28 Million USD	-27.68%
2021 Q1	10.65 Million USD	-2.19%
2021 Q2	12.32 Million USD	15.62%
2021 FY	49.6 Million USD	12.86%
2021 Q4	12.75 Million USD	-8.0%
2021 Q3	13.86 Million USD	12.51%
2020 Q2	12.26 Million USD	-2.33%
2020 Q1	12.56 Million USD	23.21%
2020 FY	43.95 Million USD	52.21%
2020 Q4	10.89 Million USD	32.47%
2020 Q3	8.22 Million USD	-32.95%
2019 Q1	1.54 Million USD	0.27%
2019 FY	28.87 Million USD	412.9%
2019 Q4	10.19 Million USD	-9.23%
2019 Q3	11.23 Million USD	89.09%
2019 Q2	5.93 Million USD	284.44%
2018 Q1	1.68 Million USD	105.24%
2018 Q2	937.12 Thousand USD	-44.47%
2018 Q3	1.46 Million USD	56.25%
2018 Q4	1.54 Million USD	5.23%
2018 FY	5.62 Million USD	67.61%
2017 FY	3.35 Million USD	-18.99%
2017 Q1	600.26 Thousand USD	-32.59%
2017 Q2	1.08 Million USD	80.36%
2017 Q3	853.67 Thousand USD	-21.15%
2017 Q4	822.27 Thousand USD	-3.68%
2016 Q3	1.48 Million USD	0.0%
2016 Q4	890.52 Thousand USD	-40.07%
2016 FY	4.14 Million USD	0.0%

Peer Operating Expenses Comparison of cbdMD, Inc.

Name	Operating Expenses	Operating Expenses Difference
China Pharma Holdings, Inc.	2.47 Million USD	-881.336%
cbdMD, Inc.	24.24 Million USD	0.0%
Zomedica Corp.	48.91 Million USD	50.427%